Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab.
Bassetti
M
M
Pizzorni
C
C
Gradoni
L
L
Del Bono
V
V
Cutolo
M
M
Viscoli
C
C
D000068879:Adalimumab; D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000150:complications*; D005260:Female; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000150:complications*; D009894:Opportunistic Infections / Q000150:complications*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D000068879:Adalimumab